HIGHLIGHTS: Thomas Schinecker - CEO of Roche
In Good Company with Nicolai Tangen
Innovations in Drug Development and Brain Treatment
This chapter explores a pharmaceutical company's robust product pipeline and its track record of annual medicine launches. It focuses on cutting-edge brain shuttle technology aimed at overcoming the blood-brain barrier, particularly for a promising Alzheimer's treatment expected to debut in the late 2020s.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
